Back to Journals » Drug Design, Development and Therapy » Volume 9

A phase I/II study of biweekly capecitabine and irinotecan plus bevacizumab as second-line chemotherapy in patients with metastatic colorectal cancer

Total article views   HTML views PDF downloads Totals
11,063 Dovepress* 9,976+ 1,673 11,649
PubMed Central* 1,087 441 1,528
Totals 11,063 2,114 13,177
*Since 16 March 2015
+Since July 2016

View citations on PubMed Central and Google Scholar